IL37 and Guillain-Barre syndrome: IL-37 level was significantly higher in patients with Guillain-Barre syndrome (GBS) [72], ankylosing spondylitis (AS) [73], and Graves' disease (GD) [74] than in healthy controls, and the expression level of IL-37 was closely related to disease activity.